Anto Biosciences
San Diego, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A microbiome biotech engineering live bacterial therapeutics for immune and metabolic diseases.
GastroenterologyImmunologyMetabolic Disease
Technology Platform
A proprietary platform for discovering, characterizing, and engineering commensal bacterial strains to develop targeted live biotherapeutic products.
Opportunities
Potential to create a new paradigm of living medicines for diseases linked to microbiome dysbiosis, with possible curative intent.
Risk Factors
Scientific risk of demonstrating consistent clinical efficacy and manufacturing/logistical challenges of delivering viable, engineered live bacteria.
Competitive Landscape
Competes in the high-potential but challenging microbiome therapeutics field, where clinical proof-of-concept for engineered products is still being established.